Literature DB >> 9169769

Clostridium perfringens urease genes are plasmid borne.

B Dupuy1, G Daube, M R Popoff, S T Cole.   

Abstract

Although many bacteria are ureolytic, and in some cases urease acts as a virulence factor, the urease phenotype has not been analyzed in the anaerobic pathogen Clostridium perfringens. In this study, approximately 2% of C. perfringens strains, representing the principal biotypes, were found to harbor the urease structural genes, ureABC, and these were localized on large plasmids that often encode, in addition, the lethal epsilon or iota toxins or the enterotoxin. This represents the first report of a plasmid-encoded urease in a gram-positive bacterium. The C. perfringens enzyme was highly similar to the ureases of other bacteria and cross-reacted with antibodies raised against the urease purified from Helicobacter pylori. Urease production was inhibited by urea and induced under growth conditions where the availability of nitrogen sources was limiting. To date, this form of regulation has been observed only for chromosomal ureABC genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169769      PMCID: PMC175321          DOI: 10.1128/iai.65.6.2313-2320.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

Review 1.  Microbial ureases: significance, regulation, and molecular characterization.

Authors:  H L Mobley; R P Hausinger
Journal:  Microbiol Rev       Date:  1989-03

Review 2.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

3.  Complete nucleotide sequence and genetic organization of the bacteriocinogenic plasmid, pIP404, from Clostridium perfringens.

Authors:  T Garnier; S T Cole
Journal:  Plasmid       Date:  1988-03       Impact factor: 3.466

4.  Genome organization of the anaerobic pathogen Clostridium perfringens.

Authors:  B Canard; S T Cole
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Testing strains of Clostridium perfringens type A isolated from diarrhoeic piglets for the presence of the enterotoxin gene.

Authors:  M van Damme-Jongsten; J Haagsma; S Notermans
Journal:  Vet Rec       Date:  1990-02-24       Impact factor: 2.695

Review 6.  Clostridium perfringens enterotoxin.

Authors:  B A McClane; P C Hanna; A P Wnek
Journal:  Microb Pathog       Date:  1988-05       Impact factor: 3.738

7.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

8.  Cloning and sequencing of the Clostridium perfringens enterotoxin gene.

Authors:  M Van Damme-Jongsten; K Wernars; S Notermans
Journal:  Antonie Van Leeuwenhoek       Date:  1989-08       Impact factor: 2.271

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  Characterization of a bacteriocinogenic plasmid from Clostridium perfringens and molecular genetic analysis of the bacteriocin-encoding gene.

Authors:  T Garnier; S T Cole
Journal:  J Bacteriol       Date:  1986-12       Impact factor: 3.490

View more
  14 in total

1.  Comparison of virulence plasmids among Clostridium perfringens type E isolates.

Authors:  Jihong Li; Kazuaki Miyamoto; Bruce A McClane
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

2.  Virulence plasmid diversity in Clostridium perfringens type D isolates.

Authors:  Sameera Sayeed; Jihong Li; Bruce A McClane
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

3.  Characterization of toxin plasmids in Clostridium perfringens type C isolates.

Authors:  Abhijit Gurjar; Jihong Li; Bruce A McClane
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

4.  Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes.

Authors:  R T Okinaka; K Cloud; O Hampton; A R Hoffmaster; K K Hill; P Keim; T M Koehler; G Lamke; S Kumano; J Mahillon; D Manter; Y Martinez; D Ricke; R Svensson; P J Jackson
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

5.  Clostridium perfringens type E animal enteritis isolates with highly conserved, silent enterotoxin gene sequences.

Authors:  S J Billington; E U Wieckowski; M R Sarker; D Bueschel; J G Songer; B A McClane
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Comparison of different criteria for interpretation of immunoglobulin G immunoblotting results for diagnosis of Helicobacter pylori infection.

Authors:  Philipp M Lepper; Angelika Möricke; Konstanze Vogt; Günter Bode; Matthias Trautmann
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

7.  Characterization of virulence plasmid diversity among Clostridium perfringens type B isolates.

Authors:  Sameera Sayeed; Jihong Li; Bruce A McClane
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

8.  Clostridium sordellii genome analysis reveals plasmid localized toxin genes encoded within pathogenicity loci.

Authors:  Edward C Couchman; Hilary P Browne; Matt Dunn; Trevor D Lawley; J Glenn Songer; Val Hall; Liljana Petrovska; Callum Vidor; Milena Awad; Dena Lyras; Neil F Fairweather
Journal:  BMC Genomics       Date:  2015-05-16       Impact factor: 3.969

9.  Comparative genomic and phenomic analysis of Clostridium difficile and Clostridium sordellii, two related pathogens with differing host tissue preference.

Authors:  Joy Scaria; Haruo Suzuki; Christopher P Ptak; Jenn-Wei Chen; Yongzhang Zhu; Xiao-Kui Guo; Yung-Fu Chang
Journal:  BMC Genomics       Date:  2015-06-10       Impact factor: 3.969

Review 10.  Bacterial urease and its role in long-lasting human diseases.

Authors:  Iwona Konieczna; Paulina Zarnowiec; Marek Kwinkowski; Beata Kolesinska; Justyna Fraczyk; Zbigniew Kaminski; Wieslaw Kaca
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.